Home » Newsletters » BioWorld

BioWorld

April 5, 1994

View Archived Issues

CALGENE SEEKS USDA APPROVAL OF ITS CANOLA

T CELL SCIENCES, SMITHKLINE HALT CLINICAL TRIAL

AGRIDYNE HAS TWO PATENTS ALLOWED, GETS SBIR GRANT

JAPANESE FIRM LICENSES CHIRON RNA PROBE

LOOK-ALIKE AUTOIMMUNE ANTIBODIES BLOCK HIV

BIOTECHNOLOGY STOCK PERFORMANCE FOR FIRST QUARTER 1994

INTERNEURON'S STROKE DRUG BEGINS PHASE II/III TRIALS

ALKERMES BEGINS RMP-7 TRIALS

APPOINTMENTS AND ADVANCEMENTS

IMMUNEX FILES NEW SUPPLEMENTAL PLA FOR LEUKINE

TO OUR READERS

HEMOSOL FILES IND FOR RED BLOOD CELL SUBSTITUTE

NEORX'S INFRINGEMENT SUIT GOES ON

MAGAININ'S MSI-78 FOR IMPETIGO DEALT A SETBACK

TEACHING CELLS TO MAKE THEIR OWN ANTI-AIDS INTERFERON

GENEMEDICINE FILES FOR IPO

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...